Cancer Immunotherapy
IL-2 Successfully Incorporated in Immuno-Gene Therapy Strategies
Published in Gene Therapy Weekly, March 30th, 1998
A major source of treatment failure of gastrointestinal cancer is the development of peritoneal metastasis. A. Tsuburaya, representing colleagues from Yokohama City University and the Kanagawa Cancer Center, Japan, presented results at the 89th Annual Meeting of the American Association for Cancer Research, held March 28 - April 1, 1998, in New Orleans, Louisiana, demonstrating the effectiveness of IL-2 delivered by a defective herpes simplex virus (HSV) vector in the treatment of peritoneal tumors (abstract "Treatment of Peritoneal Metastasis by a Defective Herpes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-03-30)
More Articles from Gene Therapy Weekly
- Prostate Cancer
Immunotherapy and Gene Therapy Used against Prostate Cancer - Cancer Gene Therapy
bax Overexpression Induces Apoptosis in Breast Cancer Cells - Cancer Gene Therapy
Adenovirus-Mediated Gene Therapy Looks Promising against Thyroid Cancer - Cancer Gene Therapy
Two Strategies Against Pancreatic Cancer Explored at Conference - Cancer Immunotherapy
p53 Stimulated Cytotoxic T Cells Target Bladder Cancer In Vivo - Genetics
NRAMP1 Gene Associated with TB Susceptibility - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
